For more than a decade, Crux Biolabs have been an Australian leader – and we’re just getting started.
Crux Biolabs dedicates itself to being an extension of the research and testing team no matter how big or small. Efficient, agile, thorough, we pride ourselves on building long standing relationships with our clients and are heavily investing in growing our team and laboratory capacity to support the high demand from our global sponsors to test and deliver time and time again.
Service in focus:
We are expert immunologists
Our highly experienced scientists offer a full suite of immunology services, and have great expertise in bespoke test development and experience across a broad range of therapeutic areas for clients across the globe. We support PK end points and PD outputs for clinical trials, are experts at performing anti-drug antibody (ADA) assays and have experience working with a wide variety of large molecules.
Our team of scientists are experts at customising biomarker detection & cell assays.
- Immunophenotyping including intracellular markers
- Intracellular cytokine staining
- CAR-T cell characteristion for cell therapy development
- Receptor occupancy (RO) measurement
- Internalisation assays
- Antibody-dependent cellular phagocytosis assays
- Phagocytosis assays
- Phospho-flow cytometry
- And more
News & EventsShow all
April 30, 2023
Discover the vision and goals of Crux Biolabs' new CEO in our in-depth interview. Learn about their background in the pharmaceutical industry and the company's plans for expanding bioanalytical services in Australia's R&D landscape.
March 9, 2023
MesoScale Discovery (MSD) immunoassays are used to measure the concentration of proteins or other molecules in biological samples. They detect multiple analytes in a single sample and are superior to Luminex because of a wider dynamic range, reduce matrix effects and increase sensitivity. MSD assays have become an important tool in clinical trials research, as they allow our scientists to quantify a variety of molecules, from cytokines and growth factors to hormones and antibodies, in complex biological matrices like blood, serum, and plasma. So, how does…
February 20, 2023
When it comes to clinical trials, it is all about the patient! Good Clinical Practice – or GCP as it is known - is a must for biolabs to ensure that their clinical trials are conducted ethically and scientifically. This international standard is essential for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials. By complying with GCP guidelines, biolabs, like ours here at Crux, can ensure that patient rights are protected, and the data and…
January 16, 2023
When it comes to places to conduct research, few places globally offer better incentives than Australia. Known as the “Australian advantage”, not only does the land down under offer a fast and pragmatic regulatory environment for clinical studies (with a review and approval process taking only 4-6 weeks for healthy volunteer studies), but it also offers a host of other incentives such as: With that in mind, note that we here at Crux Biolabs are a registered Research Service Provider…
January 16, 2023
As so many of our partners have thrilled since earlier in the year when we launched our capability to provide 21 colour flow cytometry, we just had to do a shout out to it. As you no doubt know, flow cytometry is a recognised and effective method for the detection and quantification of cellular phenotype within complex subpopulations. 21 colours refers to the number of antigens, or markers, we can detect simultaneously. These markers allow us to identify specific cell…
Download overview flyer
Looking for a quick snapshot of who Crux Biolabs are and all that we do? Download our overview flyer below.
“The Crux team are dedicated scientifically to help and collaborate with the client. They play an integral role in our clinical trails immune-monitoring requirments. They are really nice people also.”
Dr Nick Ede
“We were looking for an Australian CRO that was flexible, able to provide an unmet need with scientific rigour and attention for detail. Crux Biolabs followed through on all accounts, Catherine and her team come highly recommended.”
Dr Francesca Mercuri
“Crux Biolabs have been critical to help Pio Therapeutics advance our lead program, and meet key pre-clinical value inflection points through the development of bioanalytical and primary cell-based functional assays. In all instances, Crux executed the work with a high degree of expertise, rigour and flexibility.”
Christopher Chan PhD
“With a treasure trove of patient samples collected from our clinical studies, we wanted a trusted CRO that could help us unlock the maximum scientific value from this precious resource. The team at Crux assisted in generating a meaningful work plan, that delivered high quality data and study reports, on time and within budget. We very much look forward to working with the lovely folks at Crux again.”
Dr John Wilkinson
“Working with Crux Biolabs was a seamless, easy and straightforward process. We were very pleased with the data output as well as expertise in assay set up and design.”
Alexandra Suchowerksa PhD
“Crux has a highly experienced and dynamic team that supported us throughout the whole lifecycle of our laboratory studies. They ensured that our complex biological samples were safely transported from overseas, went through Australian customs in a timely manner and were successfully used by their skilled scientists to produce high quality biomarker results.“